ethyl 2-(3-bromo-7-chloro-2-methylpyrazolo[1,5-a]pyrimidin-5-yl)-2-methylpropanoate

Catalog No.: 
ACNZKA410
CAS No.: 
2387601-62-7
Molecular Formula: 
C13H15BrClN3O2
Molecular Weight: 
360.64
ethyl 2-(3-bromo-7-chloro-2-methylpyrazolo[1,5-a]pyrimidin-5-yl)-2-methylpropanoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$292.00InquiryInquiry
250mg98%$467.00InquiryInquiry
1g98%$1170.00InquiryInquiry
5g98%$3512.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nameethyl 2-(3-bromo-7-chloro-2-methylpyrazolo[1,5-a]pyrimidin-5-yl)-2-methylpropanoate
IUPAC Nameethyl 2-(3-bromo-7-chloro-2-methylpyrazolo[1,5-a]pyrimidin-5-yl)-2-methylpropanoate
Molecular FormulaC13H15BrClN3O2
Molecular Weight360.64
SMILESCCOC(=O)C(C)(C)C1=NC2=C(Br)C(C)=NN2C(Cl)=C1
InChI KeyPVSIRVNRKMIXMW-UHFFFAOYSA-N
SynonymPyrazolo[1,5-a]pyrimidine-5-acetic acid, 3-bromo-7-chloro-α,α,2-trimethyl-, ethyl ester
CAS No.2387601-62-7

Synthetic Route by SureRoute

1. ACNZKA410 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNZKA410 route product structure diagram
    ACNZKA4102387601-62-7
Inquiry

2. ACNZKA410 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNZKA410 route product structure diagram
    ACNZKA4102387601-62-7
Inquiry

3. ACNZKA410 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNZKA410 route product structure diagram
    ACNZKA4102387601-62-7
Inquiry

Comments (0)